CAMTA1

protein-coding

calmodulin binding transcription activator 1, the group of Calmodulin binding transcription activators |IPT domain containing

Gene summary

The protein encoded by this gene contains a CG1 DNA-binding domain, a transcription factor immunoglobulin domain, ankyrin repeats, and calmodulin-binding IQ motifs. The encoded protein is thought to be a transcription factor and may be a tumor suppressor. However, a translocation event is sometimes observed between this gene and the WWTR1 gene, with the resulting WWTR1-CAMTA1 oncoprotein leading to epithelioid hemangioendothelioma, a malignant vascular cancer. [provided by RefSeq, Mar 2017]

MANE transcript

NM_015215.4

Inheritance

AD

ClinVar variants

P:110U:517B:264

Top phenotype

Cerebellar ataxia, nonprogressive, with mental retardation

gnomAD constraint

pLI —, LoF o/e 0.09

Max pathogenic AF

—

Genomic locus

chr1:6,785,454-7,769,706

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~984.3 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

cerebellar dysfunction with variable cognitive and behavioral abnormalitiesDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0013886

Submitter: Ambry Genetics

cerebellar dysfunction with variable cognitive and behavioral abnormalitiesDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0013886

Submitter: G2P

cerebellar dysfunction with variable cognitive and behavioral abnormalitiesSTRONG

Inheritance Pattern: AD

Disease ID:MONDO:0013886

Submitter: Labcorp Genetics (formerly Invitae)

cerebellar dysfunction with variable cognitive and behavioral abnormalitiesDEFINITIVE

Inheritance Pattern: AD

Disease ID:MONDO:0013886

Submitter: ClinGen

*CAMTA1* was first reported in relation to cerebellar dysfunction with variable cognitive & behavioral abnormalities in 2011 (Mikhail et.al, PMID: 22031302). Probands are characterized by cerebellar ataxia, global developmental delay, speech delay, hypotonia, dysmorphism, behavioral abnormalities (ADHD, OCD, autistic features) and movement disorders such as tremors and myotonic dystonia. Less common phenotypes include epilepsy, GERD, velopharyngeal insufficiency, constipation, strabismus & nystagmus. Inheritance of variants is primarily de novo. Twenty one variants (missense, nonsense, frameshift, CNV: deletions & duplications) in 22 probands in 7 publications (PMIDs: 22031302, 33131045, 33677721, 30838254, 22693284, 24738973, 32157189) have been included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of pathogenicity appears to be haploinsufficiency, but a dominant negative mechanism could not be ruled out (PMID:22693284). This gene-disease relationship is also supported by experimental evidence..Both constitutive deletion of *Camta1* and conditional deletion in the G nervous system causes severe ataxia with Purkinje cell degeneration and cerebellar atrophy in mice, partially recapitulating the consequences of haploinsufficiency of the human *CAMTA1* locus (PMID: 25049392). In summary, there is definitive evidence to support the relationship between *CAMTA1* and cerebellar dysfunction with variable cognitive and behavioral abnormalities. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time. This classification was approved by the ClinGen Intellectual Disability and Autism Gene Curation Expert Panel on May 16, 2023 (SOP 9).

cerebellar dysfunction with variable cognitive and behavioral abnormalitiesSUPPORTIVE

Inheritance Pattern: AD

Disease ID:MONDO:0013886

Submitter: Orphanet

Clinical Genomic Database (CGD)

Cerebellar ataxia, nonprogressive, with mental retardationAD

Manifestation: Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 22693284Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to CAMTA1 variants in ClinVar

13 Conditions Cataloged
not providedTotal: 667
Inborn genetic diseasesTotal: 201
Cerebellar dysfunction with variable cognitive and behavioral abnormalitiesTotal: 171
not specifiedTotal: 99
CAMTA1-related disorderTotal: 73
Intellectual disabilityTotal: 10
See casesTotal: 4
Neurodevelopmental abnormalityTotal: 3

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_015215.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
7
clinvar
168
clinvar
11
clinvar
187
missense
1
clinvar
11
clinvar
498
clinvar
80
clinvar
5
clinvar
595
nonsense
14
clinvar
22
clinvar
5
clinvar
41
start loss
1
clinvar
1
frameshift
34
clinvar
13
clinvar
2
clinvar
49
splice donor/acceptor (+/-2bp)
1
clinvar
13
clinvar
4
clinvar
18
Total506051724816891

Highest pathogenic variant AF is 0.000008227157

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 105 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_015215.4RefSeqNP_056030.123MANE Select
ENST00000303635.12EnsemblENSP00000306522.623MANE Select
NM_001195563.2RefSeqNP_001182492.14Standard
NM_001242701.2RefSeqNP_001229630.14Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Pathways ConsensusPathDB

  • miR-targeted genes in muscle cell - TarBase

Biological Process

  • positive regulation of protein dephosphorylation
  • positive regulation of transcription by RNA polymerase II
  • neuromuscular process controlling balance
  • positive regulation of calcineurin-NFAT signaling cascade

Molecular Function

  • DNA-binding transcription factor activity, RNA polymerase II-specific
  • sequence-specific DNA binding

Cellular Component

  • nucleus
  • nucleolus
  • cytosol

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000303635
Coding exons
23
Length
984383
Individuals with no LoFs
125731
Homozygous LoFs
0
Heterozygous LoFs
17
Defined
125748
p
0.0000676
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense3.267251.02e+30.7120.000065211017
Missense (PolyPhen)302480.250.628845301
Synonymous0.7114174360.9570.00003263288
Loss of Function7.37776.60.09130.00000413835

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000130.00012rare
Latino/Admixed American0.0000580.000058rare
Ashkenazi Jewish00.0absent
East Asian0.000110.00011rare
Finnish0.000250.00023rare
European (Non-Finnish)0.0000460.000044rare
South Asian0.0000330.000033rare
Other00.0absent

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Transcriptional activator. May act as a tumor suppressor. {ECO:0000269|PubMed:11925432, ECO:0000269|PubMed:15709179}.;
Disease
DISEASE: Cerebellar ataxia, non-progressive, with mental retardation (CANPMR) [MIM:614756]: A neurodevelopmental disorder characterized by mildly delayed psychomotor development, early onset of cerebellar ataxia, and intellectual disability later in childhood and adult life. Other features may include neonatal hypotonia, dysarthria, and dysmetria. Brain imaging in some patients shows cerebellar atrophy. Dysmorphic facial features are variable. {ECO:0000269|PubMed:22693284}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Intolerance Scores

LoFtool
0.00455
RVIS EVS
-2.13
RVIS percentile EVS
1.5

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
E
Indispensability score
0.705

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.